4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Venus Medtech (Hangzhou) Inc. (2500) operates in the Medical Devices industry and is headquartered in Hangzhou, China with about 560 employees. Its market capitalization is roughly CNY 467 million. In the fiscal year ended 2025-12-31, 2500 reported CNY 307M in revenue and (CNY 408M) in net income.
Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | CNY 307M | CNY 471M | CNY 491M | CNY 406M |
| Gross Profit | CNY 212M | CNY 368M | CNY 389M | CNY 314M |
| Operating Income (EBIT) | (CNY 327M) | (CNY 347M) | (CNY 571M) | (CNY 635M) |
| Net Income | (CNY 408M) | (CNY 714M) | (CNY 704M) | (CNY 1.1B) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 2.5B | CNY 3.2B | CNY 4.4B | CNY 5.3B | — |
| Total Liabilities | CNY 757M | CNY 1.0B | CNY 1.5B | CNY 1.7B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2500 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms